ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 186 filers reported holding ADMA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $862,034 | -61.2% | 77,105 | -77.1% | 0.02% | -72.1% |
| Q1 2024 | $2,223,355 | +93.9% | 336,872 | +32.8% | 0.06% | +60.5% |
| Q4 2023 | $1,146,778 | +23.0% | 253,712 | -2.6% | 0.04% | +5.6% |
| Q3 2023 | $932,322 | +25.3% | 260,425 | +29.1% | 0.04% | +28.6% |
| Q2 2023 | $744,299 | +625.1% | 201,707 | +550.5% | 0.03% | +600.0% |
| Q1 2023 | $102,643 | -76.7% | 31,010 | -72.7% | 0.00% | -82.6% |
| Q4 2022 | $440,861 | +588.8% | 113,624 | +225.6% | 0.02% | +666.7% |
| Q1 2022 | $64,000 | – | 34,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |